High Tone Pelvic Floor Dysfunction

2

Review clinical trials related to High Tone Pelvic Floor Dysfunction. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Evaluation of Hyivy Floora in Managing Interstitial Cystitis/Bladder Pain Syndrome/High-tone Pelvic Floor Dysfunction

The purpose of this study is to test the safety and effectiveness of the Floora Pelvic Rehabilitation Vaginal Dilator in females with Interstitial Cystitis/ Bladder pain Syndrome (IC/BPS) and High-tome Pelvic Floor Dysfunction (HTPFD). After enrollment, participants will be given a Floora device and will be instructed to use the device at least three times per week for 12-weeks in the comfort of their home. Each session consists of 10 minutes of heat and 10 minutes of dilation. All participants will be required to attend 3 in-person clinic visits and there will be two follow-up phone-calls throughout the 16-week trial period.

Participants needed: 10
Trial details
Age: 18-80Biological sex: FemaleType: InterventionalSponsor: Wake Forest University Health SciencesUpdated: Jun 26, 2026Locations: 1
Eligibility criteria

Biological Female [+6]

History of a spinal cord injury [+11]

Status: Recruiting

Comparing Adjuvant Treatments for High Tone Pelvic Floor Dysfunction

The researchers are comparing two treatments for high tone pelvic floor dysfunction (HTPFD) in conjunction with pelvic floor physical therapy (PFPT). The goal of this study is to find out which of two extra treatments works better for people with HTPFD when they also do regular PFPT. First, the researchers will compare a muscle relaxant medicine (cyclobenzaprine IR) to using a vibrating pelvic floor massage wand. Everyone in the study will also do pelvic floor physical therapy. The researchers want to see how these treatments affect pain, sexual health, physical ability, and overall quality of life.

Participants needed: 60
Trial details
Phase: Phase 2, Phase 3Age: 18-65Biological sex: FemaleType: InterventionalSponsor: University of MichiganUpdated: Feb 20, 2026Locations: 1
Eligibility criteria

Self-reported moderate to severe chronic pelvic pain for >6 months duration at t... [+10]

Hypersensitivity or allergy to cyclobenzaprine or any component of cyclobenzapri... [+17]